Cencora
0.000958341946224848 %
24.08 %
Yet to be announced
Company Overview
Cencora, Inc. sources and distributes pharmaceutical products. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Revenue Sources
PassBased on the company's SEC filings and business operations, Cencora's primary revenue comes from pharmaceutical distribution and healthcare services. While they distribute some medications that contain alcohol as an inactive ingredient, this is considered permissible under the principle of necessity in Islamic law. The company does not derive material revenue from explicitly haram sources such as alcohol beverages, gambling, or adult entertainment.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2025 | $80.66b | $79.8b | - | - | 0.00% | 0.00% |
| March 31, 2025 | $75.45b | $74.42b | - | - | 0.00% | 0.00% |
| Dec. 31, 2024 | $81.49b | $80.78b | - | - | 0.00% | 0.00% |
| Sept. 30, 2024 | $79.05b | $78.92b | - | - | 0.00% | 0.00% |
Based on the financial data provided for the last four quarters, both interest income and interest expense are reported as $0. While this seems unusual for a company of this size, the available data suggests interest is not playing a material role in the company's operations during these periods.
Operational Ethics
PassAfter reviewing available information about Cencora's global operations and partnerships, there is no evidence of significant ongoing associations with entities involved in human rights violations. The company operates primarily in North America and Europe, with no indication of material ties to the state of Israel or the Chinese Communist Party.
Comments